AXSM vs. MATW
Compare and contrast key facts about Axsome Therapeutics, Inc. (AXSM) and Matthews International Corporation (MATW).
Performance
AXSM vs. MATW - Performance Comparison
Loading graphics...
AXSM vs. MATW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | -7.46% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -49.64% | -17.04% |
MATW Matthews International Corporation | -0.21% | -1.50% | -21.25% | 23.36% | -14.50% | 27.72% | -20.49% | -3.95% | -21.88% | -30.53% |
Fundamentals
AXSM:
$8.56B
MATW:
$812.40M
AXSM:
-$3.66
MATW:
$0.72
AXSM:
13.24
MATW:
0.58
AXSM:
96.92
MATW:
1.50
AXSM:
$638.50M
MATW:
$1.38B
AXSM:
$591.02M
MATW:
$469.95M
AXSM:
-$168.76M
MATW:
$227.64M
Returns By Period
In the year-to-date period, AXSM achieves a -7.46% return, which is significantly lower than MATW's -0.21% return. Over the past 10 years, AXSM has outperformed MATW with an annualized return of 34.16%, while MATW has yielded a comparatively lower -4.35% annualized return.
AXSM
- 1D
- 5.31%
- 1M
- 3.13%
- YTD
- -7.46%
- 6M
- 39.17%
- 1Y
- 44.92%
- 3Y*
- 39.94%
- 5Y*
- 24.07%
- 10Y*
- 34.16%
MATW
- 1D
- 2.58%
- 1M
- -2.31%
- YTD
- -0.21%
- 6M
- 8.48%
- 1Y
- 21.18%
- 3Y*
- -7.12%
- 5Y*
- -5.83%
- 10Y*
- -4.35%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AXSM vs. MATW — Risk / Return Rank
AXSM
MATW
AXSM vs. MATW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Matthews International Corporation (MATW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AXSM | MATW | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.11 | 0.56 | +0.54 |
Sortino ratioReturn per unit of downside risk | 1.90 | 1.06 | +0.84 |
Omega ratioGain probability vs. loss probability | 1.23 | 1.12 | +0.11 |
Calmar ratioReturn relative to maximum drawdown | 2.30 | 1.22 | +1.09 |
Martin ratioReturn relative to average drawdown | 5.19 | 2.66 | +2.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| AXSM | MATW | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.11 | 0.56 | +0.54 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.34 | -0.16 | +0.51 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.38 | -0.12 | +0.50 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.22 | +0.13 |
Correlation
The correlation between AXSM and MATW is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AXSM vs. MATW - Dividend Comparison
AXSM has not paid dividends to shareholders, while MATW's dividend yield for the trailing twelve months is around 3.91%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MATW Matthews International Corporation | 3.91% | 3.85% | 4.37% | 2.54% | 2.92% | 2.36% | 2.87% | 2.12% | 1.90% | 1.33% | 0.81% | 1.01% |
Drawdowns
AXSM vs. MATW - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, which is greater than MATW's maximum drawdown of -75.27%. Use the drawdown chart below to compare losses from any high point for AXSM and MATW.
Loading graphics...
Drawdown Indicators
| AXSM | MATW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.65% | -75.27% | -11.38% |
Max Drawdown (1Y)Largest decline over 1 year | -18.50% | -16.18% | -2.32% |
Max Drawdown (5Y)Largest decline over 5 years | -72.91% | -58.68% | -14.23% |
Max Drawdown (10Y)Largest decline over 10 years | -83.92% | -75.27% | -8.65% |
Current DrawdownCurrent decline from peak | -10.62% | -56.84% | +46.22% |
Average DrawdownAverage peak-to-trough decline | -40.21% | -24.53% | -15.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.21% | 7.38% | +0.83% |
Volatility
AXSM vs. MATW - Volatility Comparison
Axsome Therapeutics, Inc. (AXSM) has a higher volatility of 11.02% compared to Matthews International Corporation (MATW) at 7.71%. This indicates that AXSM's price experiences larger fluctuations and is considered to be riskier than MATW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| AXSM | MATW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.02% | 7.71% | +3.31% |
Volatility (6M)Calculated over the trailing 6-month period | 30.60% | 22.59% | +8.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.86% | 37.79% | +3.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 70.52% | 36.24% | +34.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.95% | 36.86% | +54.09% |
Financials
AXSM vs. MATW - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Matthews International Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AXSM vs. MATW - Profitability Comparison
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Axsome Therapeutics, Inc. reported a gross profit of 183.67M and revenue of 196.00M. Therefore, the gross margin over that period was 93.7%.
MATW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Matthews International Corporation reported a gross profit of 96.71M and revenue of 284.76M. Therefore, the gross margin over that period was 34.0%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Axsome Therapeutics, Inc. reported an operating income of -26.96M and revenue of 196.00M, resulting in an operating margin of -13.8%.
MATW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Matthews International Corporation reported an operating income of -15.69M and revenue of 284.76M, resulting in an operating margin of -5.5%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Axsome Therapeutics, Inc. reported a net income of -28.56M and revenue of 196.00M, resulting in a net margin of -14.6%.
MATW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Matthews International Corporation reported a net income of 43.63M and revenue of 284.76M, resulting in a net margin of 15.3%.